On the utility of cerebrospinal fluid biomarkers in canine neurological disorders
Authors:
Open Access
- 15 October 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Abstract
The cerebral biomarkers, neurofilament light chain (NfL), amyloid-β, tau, and neuron specific enolase (NSE) reflect a wide spectrum of neurological damage in the brain and spinal cord. With this study, we aimed to assess whether these biomarkers hold any potential diagnostic value for the three most common canine neurological diseases. Canines suffering from meningoencephalitis of unknown origin (MUO), brain tumors, and selected non-infectious myelopathies were included. For each diagnosis, we analyzed these biomarkers in the cerebrospinal fluid collected via cranial puncture from the cisterna magna. Elevated levels of CSF tau, NfL, and NSE were observed in MUO, with all three biomarkers being intercorrelated. Tau and NSE were increased while amyloid-β was decreased in dogs suffering from tumors. In contrast, no biomarker changes were observed in dogs with myelopathies. Covariates such as age, sex, or castration had minimal impact. CSF biomarkers may reflect molecular changes related to MUO and tumors, but not to non-infectious myelopathies. The combination of NfL, tau, and NSE may represent useful biomarkers for MUO as they reflect the same pathology and are not influenced by age.Keywords
Funding Information
- VEGA (2/0127/22)
- Agentúra na Podporu Výskumu a Vývoja (APVV-18-0515, APVV-18-0515)
This publication has 90 references indexed in Scilit:
- Efficacy assessment of an active tau immunotherapy in Alzheimer’s disease patients with amyloid and tau pathology: a post hoc analysis of the “ADAMANT” randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trialEBioMedicine, 2023
- Canine Cognitive Dysfunction (CCD) scores correlate with amyloid beta 42 levels in dog brain tissueGeroScience, 2021
- Plasma Neurofilament Light Chain as a Translational Biomarker of Aging and Neurodegeneration in DogsMolecular Neurobiology, 2020
- Neuron-specific enolase levels as a marker for possible neuronal damage in idiopathic intracranial hypertensionActa Neurologica Belgica, 2017
- Tau hyperphosphorylation in synaptosomes and neuroinflammation are associated with canine cognitive impairmentJournal of Comparative Neurology, 2015
- Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects2015
- Perspectives on Meningoencephalomyelitis of Unknown OriginVeterinary Clinics of North America: Small Animal Practice, 2014
- Inflammatory Diseases of the Spine in Small AnimalsVeterinary Clinics of North America: Small Animal Practice, 2010
- MRI of Brain Disease in Veterinary Patients Part 2: Acquired Brain DisordersVeterinary Clinics of North America: Small Animal Practice, 2010
- Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: Possible use for assessment of a therapeutic regimenBrain Research, 2007